

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.47438246 |
| 2 | viral transcription (GO:0019083) | 6.27775100 |
| 3 | translational termination (GO:0006415) | 5.97410184 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.80267436 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.58035837 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 5.51135579 |
| 7 | ribosomal large subunit biogenesis (GO:0042273) | 5.49933121 |
| 8 | protein targeting to ER (GO:0045047) | 5.45563318 |
| 9 | protein localization to endoplasmic reticulum (GO:0070972) | 5.21725907 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.18105234 |
| 11 | translational elongation (GO:0006414) | 4.98994948 |
| 12 | DNA deamination (GO:0045006) | 4.83871968 |
| 13 | viral life cycle (GO:0019058) | 4.73720515 |
| 14 | cellular protein complex disassembly (GO:0043624) | 4.56138652 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.51509047 |
| 16 | proteasome assembly (GO:0043248) | 4.41893177 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.39217722 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 4.19945771 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.19945771 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 4.18066750 |
| 21 | translational initiation (GO:0006413) | 4.17291239 |
| 22 | base-excision repair, AP site formation (GO:0006285) | 3.91420250 |
| 23 | protein complex disassembly (GO:0043241) | 3.90825367 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.82458724 |
| 25 | macromolecular complex disassembly (GO:0032984) | 3.77698067 |
| 26 | translation (GO:0006412) | 3.77463958 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.76043946 |
| 28 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.75958748 |
| 29 | protein neddylation (GO:0045116) | 3.67984737 |
| 30 | meiotic chromosome segregation (GO:0045132) | 3.61990150 |
| 31 | respiratory chain complex IV assembly (GO:0008535) | 3.58946749 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.51741837 |
| 33 | termination of RNA polymerase III transcription (GO:0006386) | 3.51741837 |
| 34 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.51224667 |
| 35 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.51224667 |
| 36 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.49280993 |
| 37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46699988 |
| 38 | protein targeting to membrane (GO:0006612) | 3.45833741 |
| 39 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.45730783 |
| 40 | deoxyribose phosphate catabolic process (GO:0046386) | 3.43656266 |
| 41 | respiratory electron transport chain (GO:0022904) | 3.43025600 |
| 42 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.42351325 |
| 43 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.42351325 |
| 44 | NADH dehydrogenase complex assembly (GO:0010257) | 3.42351325 |
| 45 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.42052806 |
| 46 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.39630640 |
| 47 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.37646619 |
| 48 | electron transport chain (GO:0022900) | 3.37504487 |
| 49 | C-terminal protein lipidation (GO:0006501) | 3.37227276 |
| 50 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36844296 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.36844296 |
| 52 | telomere maintenance via recombination (GO:0000722) | 3.34817199 |
| 53 | GTP biosynthetic process (GO:0006183) | 3.33679627 |
| 54 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31855921 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31526957 |
| 56 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.29859828 |
| 57 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.29859828 |
| 58 | protein complex biogenesis (GO:0070271) | 3.29076311 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.28905450 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.28905450 |
| 61 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.28905450 |
| 62 | cellular component biogenesis (GO:0044085) | 3.24890287 |
| 63 | mRNA catabolic process (GO:0006402) | 3.24030928 |
| 64 | purine nucleobase biosynthetic process (GO:0009113) | 3.21983620 |
| 65 | DNA ligation (GO:0006266) | 3.20426901 |
| 66 | peptidyl-histidine modification (GO:0018202) | 3.18406007 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.15213479 |
| 68 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.15213479 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.13240307 |
| 70 | signal peptide processing (GO:0006465) | 3.12232084 |
| 71 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.11226334 |
| 72 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.10604791 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09730059 |
| 74 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.09231919 |
| 75 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.05880268 |
| 76 | iron-sulfur cluster assembly (GO:0016226) | 3.03466667 |
| 77 | metallo-sulfur cluster assembly (GO:0031163) | 3.03466667 |
| 78 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03426959 |
| 79 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.01519471 |
| 80 | chaperone-mediated protein transport (GO:0072321) | 3.00864715 |
| 81 | rRNA processing (GO:0006364) | 3.00819226 |
| 82 | cytochrome complex assembly (GO:0017004) | 3.00737912 |
| 83 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.00552634 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.00243733 |
| 85 | GDP-mannose metabolic process (GO:0019673) | 2.98586487 |
| 86 | RNA catabolic process (GO:0006401) | 2.98357724 |
| 87 | C-terminal protein amino acid modification (GO:0018410) | 2.97033372 |
| 88 | oxidative phosphorylation (GO:0006119) | 2.96318069 |
| 89 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.95876450 |
| 90 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.95036047 |
| 91 | DNA damage response, detection of DNA damage (GO:0042769) | 2.94329266 |
| 92 | mitotic recombination (GO:0006312) | 2.93125336 |
| 93 | CENP-A containing nucleosome assembly (GO:0034080) | 2.92259636 |
| 94 | rRNA metabolic process (GO:0016072) | 2.91886625 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 2.90284625 |
| 96 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.88756064 |
| 97 | DNA strand elongation (GO:0022616) | 2.88090864 |
| 98 | sequestering of actin monomers (GO:0042989) | 2.87967373 |
| 99 | adenosine metabolic process (GO:0046085) | 2.87725824 |
| 100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.86692888 |
| 101 | telomere maintenance via telomere lengthening (GO:0010833) | 2.86496270 |
| 102 | purine nucleotide salvage (GO:0032261) | 2.86227793 |
| 103 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.85788757 |
| 104 | pseudouridine synthesis (GO:0001522) | 2.85390618 |
| 105 | deoxyribose phosphate metabolic process (GO:0019692) | 2.84520954 |
| 106 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84009769 |
| 107 | protein deneddylation (GO:0000338) | 2.82577315 |
| 108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.82372200 |
| 109 | positive regulation of ligase activity (GO:0051351) | 2.82174827 |
| 110 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.81845608 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80931123 |
| 112 | CTP biosynthetic process (GO:0006241) | 2.80477335 |
| 113 | CTP metabolic process (GO:0046036) | 2.80477335 |
| 114 | chromatin remodeling at centromere (GO:0031055) | 2.79396212 |
| 115 | 7-methylguanosine mRNA capping (GO:0006370) | 2.78623613 |
| 116 | tRNA methylation (GO:0030488) | 2.78408686 |
| 117 | rRNA modification (GO:0000154) | 2.77024518 |
| 118 | RNA capping (GO:0036260) | 2.76225730 |
| 119 | 7-methylguanosine RNA capping (GO:0009452) | 2.76225730 |
| 120 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.76023040 |
| 121 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.75553913 |
| 122 | UTP biosynthetic process (GO:0006228) | 2.74756763 |
| 123 | spliceosomal snRNP assembly (GO:0000387) | 2.73787866 |
| 124 | regulation of mitochondrial translation (GO:0070129) | 2.72673334 |
| 125 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.71215664 |
| 126 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.71005391 |
| 127 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.71005391 |
| 128 | histone mRNA metabolic process (GO:0008334) | 2.70913682 |
| 129 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.69501664 |
| 130 | mismatch repair (GO:0006298) | 2.69049020 |
| 131 | mannosylation (GO:0097502) | 2.67754589 |
| 132 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.66541110 |
| 133 | reciprocal DNA recombination (GO:0035825) | 2.65569220 |
| 134 | reciprocal meiotic recombination (GO:0007131) | 2.65569220 |
| 135 | spliceosomal complex assembly (GO:0000245) | 2.65386029 |
| 136 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.65242863 |
| 137 | tRNA modification (GO:0006400) | 2.65220706 |
| 138 | nucleoside salvage (GO:0043174) | 2.64035682 |
| 139 | viral mRNA export from host cell nucleus (GO:0046784) | 2.63927469 |
| 140 | positive regulation of cell cycle arrest (GO:0071158) | 2.63571323 |
| 141 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.63094753 |
| 142 | termination of RNA polymerase I transcription (GO:0006363) | 2.61791299 |
| 143 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.61367416 |
| 144 | lymphoid progenitor cell differentiation (GO:0002320) | 2.61225159 |
| 145 | DNA-templated transcription, termination (GO:0006353) | 2.60112917 |
| 146 | platelet dense granule organization (GO:0060155) | 2.59674302 |
| 147 | actin nucleation (GO:0045010) | 2.59582527 |
| 148 | tRNA processing (GO:0008033) | 2.59276888 |
| 149 | protein targeting to mitochondrion (GO:0006626) | 2.58004856 |
| 150 | DNA replication checkpoint (GO:0000076) | 2.57735411 |
| 151 | deoxyribonucleotide catabolic process (GO:0009264) | 2.54567213 |
| 152 | GPI anchor biosynthetic process (GO:0006506) | 2.52906166 |
| 153 | DNA replication initiation (GO:0006270) | 2.49702948 |
| 154 | interferon-gamma production (GO:0032609) | 2.49360313 |
| 155 | cullin deneddylation (GO:0010388) | 2.48664777 |
| 156 | maturation of 5.8S rRNA (GO:0000460) | 2.48104458 |
| 157 | rRNA methylation (GO:0031167) | 2.48038144 |
| 158 | ncRNA processing (GO:0034470) | 2.47746077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.93115867 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.74058832 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.25695869 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.84280115 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.74323266 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.70876868 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.42082900 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.27948290 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.19611393 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03344261 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.87414963 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.85045240 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.77390841 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76421610 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.67376903 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51389021 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.45239953 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.45193529 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42462053 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.41081657 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33667414 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.30031544 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.25019473 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24583979 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.23916653 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22103085 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.16797706 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.15662298 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11374772 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.11190267 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06496455 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05567487 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.01878293 |
| 34 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01860254 |
| 35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.01503624 |
| 36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98302195 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.97602844 |
| 38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.96613839 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95251835 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94912728 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94889888 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.94702785 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87120146 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82372850 |
| 45 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.81412652 |
| 46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70205818 |
| 47 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.68876926 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60070123 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55338823 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.54652920 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52219608 |
| 52 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.51989211 |
| 53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51850274 |
| 54 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.48295006 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.44536205 |
| 56 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44118439 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43285693 |
| 58 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.41649440 |
| 59 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.40753682 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33205096 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32967195 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.31097084 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30277269 |
| 64 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27462261 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23231515 |
| 66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22722113 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21844508 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19503543 |
| 69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18881938 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16949889 |
| 71 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16043597 |
| 72 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15728235 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14692446 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14410700 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13165453 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12240095 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11528816 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08559127 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07874155 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05248850 |
| 81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.04431724 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03158876 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01302410 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.01122127 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98064322 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97802601 |
| 87 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96690310 |
| 88 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94655844 |
| 89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94230194 |
| 90 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94080211 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93716967 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91433497 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91228053 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88801916 |
| 95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88625343 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 0.88209434 |
| 97 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88095066 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84645095 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84443104 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84422919 |
| 101 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82838255 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82721749 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82040712 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81856107 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.81327670 |
| 106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81246305 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.81125232 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79989823 |
| 109 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77413040 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75546324 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74985842 |
| 112 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74853368 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74027673 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 0.72293184 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.72181364 |
| 116 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.71510487 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.71362022 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71220676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.57073577 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.00058270 |
| 3 | MP0003136_yellow_coat_color | 3.11139512 |
| 4 | MP0004381_abnormal_hair_follicle | 3.08625888 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.85670864 |
| 6 | MP0005671_abnormal_response_to | 2.80632442 |
| 7 | MP0003724_increased_susceptibility_to | 2.67075140 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.64902848 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.64202809 |
| 10 | MP0001188_hyperpigmentation | 2.46089167 |
| 11 | MP0008058_abnormal_DNA_repair | 2.38020378 |
| 12 | MP0003693_abnormal_embryo_hatching | 2.30517944 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.23938896 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.22247396 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.13471803 |
| 16 | MP0005409_darkened_coat_color | 2.11557634 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08658604 |
| 18 | MP0002132_abnormal_respiratory_system | 2.07169486 |
| 19 | MP0009785_altered_susceptibility_to | 2.06653740 |
| 20 | MP0002095_abnormal_skin_pigmentation | 1.91576307 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.90874448 |
| 22 | MP0005174_abnormal_tail_pigmentation | 1.82080486 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.81745712 |
| 24 | MP0001764_abnormal_homeostasis | 1.78399598 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.77435964 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 1.72996616 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.72566848 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.70701999 |
| 29 | MP0001800_abnormal_humoral_immune | 1.69965863 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.68720330 |
| 31 | MP0000685_abnormal_immune_system | 1.67220850 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.64791449 |
| 33 | MP0009764_decreased_sensitivity_to | 1.61514236 |
| 34 | MP0001819_abnormal_immune_cell | 1.61356990 |
| 35 | MP0002723_abnormal_immune_serum | 1.59646182 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.57568891 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.56045389 |
| 38 | MP0002398_abnormal_bone_marrow | 1.55363664 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.54876498 |
| 40 | MP0000490_abnormal_crypts_of | 1.54674999 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.52977748 |
| 42 | MP0001790_abnormal_immune_system | 1.52205192 |
| 43 | MP0005387_immune_system_phenotype | 1.52205192 |
| 44 | MP0002009_preneoplasia | 1.50970839 |
| 45 | MP0005025_abnormal_response_to | 1.50604733 |
| 46 | MP0003077_abnormal_cell_cycle | 1.47447857 |
| 47 | MP0008932_abnormal_embryonic_tissue | 1.46306767 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.44231505 |
| 49 | MP0000716_abnormal_immune_system | 1.41399808 |
| 50 | MP0002102_abnormal_ear_morphology | 1.41377323 |
| 51 | MP0003786_premature_aging | 1.41123255 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.40311338 |
| 53 | MP0000358_abnormal_cell_content/ | 1.37733558 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.37624972 |
| 55 | MP0002938_white_spotting | 1.36936122 |
| 56 | MP0005360_urolithiasis | 1.36417585 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.36214826 |
| 58 | MP0002405_respiratory_system_inflammati | 1.35814243 |
| 59 | MP0008469_abnormal_protein_level | 1.34590782 |
| 60 | MP0008057_abnormal_DNA_replication | 1.34471046 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.34046872 |
| 62 | MP0002722_abnormal_immune_system | 1.30930626 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.29430342 |
| 64 | MP0001529_abnormal_vocalization | 1.29278747 |
| 65 | MP0002933_joint_inflammation | 1.28532271 |
| 66 | MP0002429_abnormal_blood_cell | 1.22745992 |
| 67 | MP0003866_abnormal_defecation | 1.21757878 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.19823782 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.18479101 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.17688336 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.17537215 |
| 72 | MP0002419_abnormal_innate_immunity | 1.16383495 |
| 73 | MP0005332_abnormal_amino_acid | 1.15420375 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.13425684 |
| 75 | MP0001919_abnormal_reproductive_system | 1.08840154 |
| 76 | MP0006082_CNS_inflammation | 1.08142465 |
| 77 | MP0005083_abnormal_biliary_tract | 1.08123427 |
| 78 | MP0005646_abnormal_pituitary_gland | 1.07280317 |
| 79 | MP0004147_increased_porphyrin_level | 1.07030448 |
| 80 | MP0000613_abnormal_salivary_gland | 1.06106122 |
| 81 | MP0001853_heart_inflammation | 1.05361301 |
| 82 | MP0005171_absent_coat_pigmentation | 1.04857403 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 1.04161906 |
| 84 | MP0006054_spinal_hemorrhage | 1.04110018 |
| 85 | MP0005365_abnormal_bile_salt | 1.03913607 |
| 86 | MP0003718_maternal_effect | 1.03614725 |
| 87 | MP0003436_decreased_susceptibility_to | 1.01055733 |
| 88 | MP0002163_abnormal_gland_morphology | 1.00911504 |
| 89 | MP0000566_synostosis | 1.00725168 |
| 90 | MP0000049_abnormal_middle_ear | 0.99721403 |
| 91 | MP0002006_tumorigenesis | 0.99456580 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.97957537 |
| 93 | MP0001873_stomach_inflammation | 0.96789195 |
| 94 | MP0008873_increased_physiological_sensi | 0.94966095 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.94163709 |
| 96 | MP0003011_delayed_dark_adaptation | 0.94128102 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.92084233 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.90753119 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.90265984 |
| 100 | MP0003195_calcinosis | 0.90218422 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.89714991 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88835642 |
| 103 | MP0002177_abnormal_outer_ear | 0.88822746 |
| 104 | MP0005253_abnormal_eye_physiology | 0.87602124 |
| 105 | MP0009697_abnormal_copulation | 0.87270525 |
| 106 | MP0005408_hypopigmentation | 0.86186990 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.85766181 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.83973755 |
| 109 | MP0001661_extended_life_span | 0.83407425 |
| 110 | MP0008872_abnormal_physiological_respon | 0.82471343 |
| 111 | MP0000858_altered_metastatic_potential | 0.82269384 |
| 112 | MP0005389_reproductive_system_phenotype | 0.82130414 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.81970808 |
| 114 | MP0002210_abnormal_sex_determination | 0.81794095 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.81577801 |
| 116 | MP0001186_pigmentation_phenotype | 0.80920971 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.80235170 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.79314250 |
| 119 | MP0005410_abnormal_fertilization | 0.78159162 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.76198577 |
| 121 | MP0002160_abnormal_reproductive_system | 0.75631025 |
| 122 | MP0003186_abnormal_redox_activity | 0.75545149 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.74617138 |
| 124 | MP0004142_abnormal_muscle_tone | 0.73969887 |
| 125 | MP0005499_abnormal_olfactory_system | 0.73340926 |
| 126 | MP0005394_taste/olfaction_phenotype | 0.73340926 |
| 127 | MP0008004_abnormal_stomach_pH | 0.72926955 |
| 128 | MP0001905_abnormal_dopamine_level | 0.70051912 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.69633138 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.69310971 |
| 131 | MP0001984_abnormal_olfaction | 0.66521450 |
| 132 | MP0000313_abnormal_cell_death | 0.66424031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.53397300 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.40104178 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.37181065 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.64781345 |
| 5 | Macrocytic anemia (HP:0001972) | 3.51677011 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.45857096 |
| 7 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.40731967 |
| 8 | Increased muscle lipid content (HP:0009058) | 3.38723648 |
| 9 | Type I transferrin isoform profile (HP:0003642) | 3.38145984 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 3.33273961 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.28765702 |
| 12 | Cerebral edema (HP:0002181) | 3.27170350 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21044243 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21044243 |
| 15 | Hepatic necrosis (HP:0002605) | 3.14191631 |
| 16 | Aplastic anemia (HP:0001915) | 3.13715704 |
| 17 | Pallor (HP:0000980) | 3.12098511 |
| 18 | Increased CSF lactate (HP:0002490) | 3.08417496 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.01180018 |
| 20 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.97847202 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95134291 |
| 22 | Microvesicular hepatic steatosis (HP:0001414) | 2.94949317 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 2.94498086 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.84093147 |
| 25 | Hypothermia (HP:0002045) | 2.71479250 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 2.70525158 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.66485168 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65232142 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.64905759 |
| 30 | Abnormal hemoglobin (HP:0011902) | 2.63474196 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52462507 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.52174809 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.51145308 |
| 34 | Increased serum lactate (HP:0002151) | 2.49453247 |
| 35 | Lethargy (HP:0001254) | 2.49247547 |
| 36 | Increased IgM level (HP:0003496) | 2.45434052 |
| 37 | Acute encephalopathy (HP:0006846) | 2.41944783 |
| 38 | Exertional dyspnea (HP:0002875) | 2.40406912 |
| 39 | T lymphocytopenia (HP:0005403) | 2.39370823 |
| 40 | IgM deficiency (HP:0002850) | 2.33207089 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.33090607 |
| 42 | B lymphocytopenia (HP:0010976) | 2.33090607 |
| 43 | True hermaphroditism (HP:0010459) | 2.32433632 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.32121047 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.32121047 |
| 46 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32121047 |
| 47 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32121047 |
| 48 | Neutropenia (HP:0001875) | 2.27764355 |
| 49 | Optic disc pallor (HP:0000543) | 2.26963973 |
| 50 | Progressive microcephaly (HP:0000253) | 2.26237118 |
| 51 | IgG deficiency (HP:0004315) | 2.26070242 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.25953250 |
| 53 | Opisthotonus (HP:0002179) | 2.25807853 |
| 54 | CNS demyelination (HP:0007305) | 2.20704007 |
| 55 | Thrombocytosis (HP:0001894) | 2.17958969 |
| 56 | 11 pairs of ribs (HP:0000878) | 2.17332982 |
| 57 | Exercise intolerance (HP:0003546) | 2.16277031 |
| 58 | Dry hair (HP:0011359) | 2.13315992 |
| 59 | Meningitis (HP:0001287) | 2.12994227 |
| 60 | Respiratory difficulties (HP:0002880) | 2.12592442 |
| 61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.12317903 |
| 62 | Leukodystrophy (HP:0002415) | 2.12215335 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11936772 |
| 64 | Obstructive lung disease (HP:0006536) | 2.11936772 |
| 65 | Patchy hypopigmentation of hair (HP:0011365) | 2.11670877 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.09870620 |
| 67 | Abnormality of midbrain morphology (HP:0002418) | 2.09870620 |
| 68 | Methylmalonic aciduria (HP:0012120) | 2.08911936 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.08566322 |
| 70 | Testicular atrophy (HP:0000029) | 2.08551262 |
| 71 | Petechiae (HP:0000967) | 2.08461810 |
| 72 | Abnormality of the axillary hair (HP:0100134) | 2.08178529 |
| 73 | Abnormality of secondary sexual hair (HP:0009888) | 2.08178529 |
| 74 | Poikiloderma (HP:0001029) | 2.07966837 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.06410269 |
| 76 | Oral leukoplakia (HP:0002745) | 2.05452711 |
| 77 | Pulmonary fibrosis (HP:0002206) | 2.05041225 |
| 78 | Pancytopenia (HP:0001876) | 2.04593084 |
| 79 | Muscle fiber atrophy (HP:0100295) | 2.03391681 |
| 80 | Abnormality of the columella (HP:0009929) | 2.00522868 |
| 81 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.00122132 |
| 82 | Lactic acidosis (HP:0003128) | 1.99163483 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 1.99071055 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98964607 |
| 85 | Recurrent abscess formation (HP:0002722) | 1.98422518 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 1.98173197 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97834467 |
| 88 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97488052 |
| 89 | Abnormality of T cells (HP:0002843) | 1.97090663 |
| 90 | Agammaglobulinemia (HP:0004432) | 1.96963932 |
| 91 | Abnormality of renal resorption (HP:0011038) | 1.96855655 |
| 92 | Respiratory failure (HP:0002878) | 1.95338117 |
| 93 | Absent thumb (HP:0009777) | 1.94661945 |
| 94 | Recurrent bronchitis (HP:0002837) | 1.94639945 |
| 95 | Chromsome breakage (HP:0040012) | 1.94162248 |
| 96 | White forelock (HP:0002211) | 1.92666289 |
| 97 | Attenuation of retinal blood vessels (HP:0007843) | 1.92569847 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 1.92308727 |
| 99 | Triphalangeal thumb (HP:0001199) | 1.92301254 |
| 100 | Abnormality of the preputium (HP:0100587) | 1.90821446 |
| 101 | Pancreatic fibrosis (HP:0100732) | 1.90051106 |
| 102 | Emotional lability (HP:0000712) | 1.89940968 |
| 103 | Prolonged bleeding time (HP:0003010) | 1.89414690 |
| 104 | Chronic otitis media (HP:0000389) | 1.88239857 |
| 105 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87761194 |
| 106 | Dicarboxylic aciduria (HP:0003215) | 1.87761194 |
| 107 | Myositis (HP:0100614) | 1.87640625 |
| 108 | Autoimmune hemolytic anemia (HP:0001890) | 1.87566821 |
| 109 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87023813 |
| 110 | Lymphoma (HP:0002665) | 1.86837803 |
| 111 | Congenital stationary night blindness (HP:0007642) | 1.86030196 |
| 112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85868271 |
| 113 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84467764 |
| 114 | Encephalitis (HP:0002383) | 1.84261388 |
| 115 | Stomatitis (HP:0010280) | 1.84005679 |
| 116 | Squamous cell carcinoma (HP:0002860) | 1.83373727 |
| 117 | Asplenia (HP:0001746) | 1.82526340 |
| 118 | Cleft eyelid (HP:0000625) | 1.81386593 |
| 119 | Methylmalonic acidemia (HP:0002912) | 1.80656222 |
| 120 | Dyschromatopsia (HP:0007641) | 1.80506737 |
| 121 | Hypoplasia of the pons (HP:0012110) | 1.80108175 |
| 122 | Abnormality of alanine metabolism (HP:0010916) | 1.79208588 |
| 123 | Hyperalaninemia (HP:0003348) | 1.79208588 |
| 124 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79208588 |
| 125 | Pancreatic cysts (HP:0001737) | 1.79107845 |
| 126 | Median cleft lip (HP:0000161) | 1.79000612 |
| 127 | Microretrognathia (HP:0000308) | 1.78734661 |
| 128 | Renal cortical cysts (HP:0000803) | 1.78391677 |
| 129 | Granulocytopenia (HP:0001913) | 1.78150772 |
| 130 | Hyperglycinemia (HP:0002154) | 1.77384358 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.76634528 |
| 132 | Premature graying of hair (HP:0002216) | 1.75956542 |
| 133 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75952198 |
| 134 | Acute hepatic failure (HP:0006554) | 1.73985836 |
| 135 | Combined immunodeficiency (HP:0005387) | 1.73623103 |
| 136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.73066268 |
| 137 | Entropion (HP:0000621) | 1.70669009 |
| 138 | Vomiting (HP:0002013) | 1.70146678 |
| 139 | Facial diplegia (HP:0001349) | 1.69719018 |
| 140 | Medial flaring of the eyebrow (HP:0010747) | 1.69015356 |
| 141 | Metaphyseal dysplasia (HP:0100255) | 1.66587766 |
| 142 | Multiple enchondromatosis (HP:0005701) | 1.66583675 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.65963725 |
| 144 | Abnormality of eosinophils (HP:0001879) | 1.64451651 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64068424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.06196529 |
| 2 | STK16 | 3.56506731 |
| 3 | NME2 | 3.07552585 |
| 4 | BCKDK | 3.06710013 |
| 5 | VRK2 | 2.97637188 |
| 6 | IRAK4 | 2.52857146 |
| 7 | CASK | 2.25348066 |
| 8 | EIF2AK1 | 2.24808134 |
| 9 | IRAK3 | 2.21239196 |
| 10 | TXK | 2.20711642 |
| 11 | MKNK2 | 2.17678626 |
| 12 | TNIK | 2.16484614 |
| 13 | SRPK1 | 2.10283496 |
| 14 | SCYL2 | 2.09599636 |
| 15 | TESK1 | 2.05567915 |
| 16 | IRAK1 | 2.04547296 |
| 17 | PBK | 2.04164735 |
| 18 | VRK1 | 1.96313383 |
| 19 | TEC | 1.92763518 |
| 20 | BUB1 | 1.87299363 |
| 21 | CDK19 | 1.85730275 |
| 22 | DYRK3 | 1.84508765 |
| 23 | NLK | 1.83962529 |
| 24 | IRAK2 | 1.75561334 |
| 25 | MAP4K2 | 1.73353883 |
| 26 | WEE1 | 1.64244117 |
| 27 | MKNK1 | 1.60312527 |
| 28 | CLK1 | 1.59781024 |
| 29 | PDK2 | 1.55709805 |
| 30 | EIF2AK3 | 1.54403401 |
| 31 | CDK8 | 1.51872164 |
| 32 | BLK | 1.50898256 |
| 33 | MST4 | 1.48636966 |
| 34 | LIMK1 | 1.42994412 |
| 35 | BMPR1B | 1.40733638 |
| 36 | TRIM28 | 1.40396784 |
| 37 | PIM2 | 1.35145138 |
| 38 | NME1 | 1.31700782 |
| 39 | MAP4K1 | 1.28043712 |
| 40 | KIT | 1.27537178 |
| 41 | ZAK | 1.24898739 |
| 42 | ARAF | 1.22258190 |
| 43 | ACVR1B | 1.21156687 |
| 44 | MAP3K14 | 1.17279470 |
| 45 | YES1 | 1.16925193 |
| 46 | CAMKK2 | 1.12735368 |
| 47 | BTK | 1.11205127 |
| 48 | ERN1 | 1.08824810 |
| 49 | EIF2AK2 | 1.06344289 |
| 50 | CSNK1G2 | 1.06276129 |
| 51 | CDK3 | 1.05771983 |
| 52 | RPS6KA4 | 1.05579819 |
| 53 | GRK6 | 1.04700633 |
| 54 | IKBKE | 1.02146358 |
| 55 | ADRBK2 | 1.01922855 |
| 56 | MUSK | 0.99554476 |
| 57 | MAPKAPK5 | 0.93811168 |
| 58 | PLK4 | 0.92127515 |
| 59 | MAP2K7 | 0.86965583 |
| 60 | NEK9 | 0.85048799 |
| 61 | ZAP70 | 0.84219596 |
| 62 | ITK | 0.83882144 |
| 63 | MAPK15 | 0.83874912 |
| 64 | ERBB3 | 0.82858829 |
| 65 | RPS6KA5 | 0.81314316 |
| 66 | PRKCQ | 0.81078008 |
| 67 | TESK2 | 0.80787532 |
| 68 | TNK2 | 0.79022411 |
| 69 | DAPK1 | 0.77502395 |
| 70 | BMPR2 | 0.76582572 |
| 71 | TGFBR1 | 0.74948080 |
| 72 | DYRK2 | 0.72445274 |
| 73 | LCK | 0.72353118 |
| 74 | KDR | 0.72122065 |
| 75 | CDK7 | 0.69723953 |
| 76 | IKBKB | 0.69255860 |
| 77 | NUAK1 | 0.68730567 |
| 78 | WNK4 | 0.65821334 |
| 79 | GRK7 | 0.64808583 |
| 80 | ABL2 | 0.64642763 |
| 81 | MYLK | 0.64240059 |
| 82 | LYN | 0.63084619 |
| 83 | FRK | 0.62919281 |
| 84 | BRSK2 | 0.62718214 |
| 85 | SYK | 0.61128498 |
| 86 | NEK1 | 0.60237012 |
| 87 | CSNK1G3 | 0.60130812 |
| 88 | GRK1 | 0.59204030 |
| 89 | TIE1 | 0.57812539 |
| 90 | FES | 0.57475250 |
| 91 | FLT3 | 0.56860302 |
| 92 | TYK2 | 0.56844006 |
| 93 | PIM1 | 0.56211754 |
| 94 | BRAF | 0.56121892 |
| 95 | CDK9 | 0.55737960 |
| 96 | CSNK1A1L | 0.55299292 |
| 97 | CSNK2A1 | 0.55227062 |
| 98 | PIK3CA | 0.54939491 |
| 99 | MAPK13 | 0.54758482 |
| 100 | MAP3K5 | 0.54377950 |
| 101 | AURKA | 0.53576068 |
| 102 | ATR | 0.53360095 |
| 103 | CSNK1G1 | 0.53180666 |
| 104 | AURKB | 0.52650320 |
| 105 | PLK1 | 0.51210235 |
| 106 | TAOK3 | 0.51100315 |
| 107 | SIK3 | 0.50939720 |
| 108 | MAP3K13 | 0.48979511 |
| 109 | PRKD2 | 0.48583319 |
| 110 | DAPK3 | 0.48296994 |
| 111 | NEK6 | 0.46645367 |
| 112 | TBK1 | 0.46496706 |
| 113 | JAK3 | 0.46170761 |
| 114 | CSK | 0.45784871 |
| 115 | PINK1 | 0.45533514 |
| 116 | RPS6KB2 | 0.45232340 |
| 117 | MARK3 | 0.45008069 |
| 118 | PAK1 | 0.44943684 |
| 119 | CDK6 | 0.44367508 |
| 120 | STK4 | 0.43437910 |
| 121 | MAP3K11 | 0.43318434 |
| 122 | CDK4 | 0.43184409 |
| 123 | BCR | 0.42860742 |
| 124 | MAPKAPK3 | 0.42709322 |
| 125 | TRPM7 | 0.41945910 |
| 126 | ILK | 0.41684129 |
| 127 | CDC7 | 0.40618225 |
| 128 | CSNK2A2 | 0.40162395 |
| 129 | STK10 | 0.39344943 |
| 130 | CHEK2 | 0.38286847 |
| 131 | OBSCN | 0.38218270 |
| 132 | ADRBK1 | 0.38190490 |
| 133 | TSSK6 | 0.38103887 |
| 134 | MAP2K6 | 0.37294158 |
| 135 | CSF1R | 0.36864542 |
| 136 | MAP3K12 | 0.36863841 |
| 137 | DYRK1B | 0.36619777 |
| 138 | CCNB1 | 0.36089134 |
| 139 | MATK | 0.29980970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.49889134 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.54122406 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.32070112 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.07574526 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.88791296 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.76872029 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.68222867 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.59111300 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38029768 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.31932941 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.26201995 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.24146583 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19849523 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.19475804 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11667748 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.04943115 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.90282779 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.81978791 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67014055 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65772541 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63762801 |
| 22 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60088538 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56579116 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.52248860 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44746852 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.38598852 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37822541 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31704583 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25409754 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22024331 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17191558 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16372164 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15764593 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.14806290 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12162870 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.09367070 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07574762 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07567875 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07164473 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02977789 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01888538 |
| 42 | Cell cycle_Homo sapiens_hsa04110 | 1.01000400 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00670907 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.00158038 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.99570819 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99160499 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.99133041 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98613042 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94169109 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92975035 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92219044 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91414049 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88359113 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87394394 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87308259 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86503084 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85821676 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85185256 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84339756 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82734702 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79462811 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79121164 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74850390 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74295316 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71638093 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.70783371 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69922734 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68238226 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67897774 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67759585 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67651120 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67030172 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.65953352 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65182662 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65083824 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64207479 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63950964 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63784980 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63655592 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60854745 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59890916 |
| 82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57560503 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53938467 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53802395 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52666343 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49132396 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46702673 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46350277 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46158082 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43768095 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43055467 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41655991 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41302763 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41169466 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.41080513 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40857179 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40118838 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39924457 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39332729 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39218622 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39202687 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.38712161 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37969378 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37361471 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37331796 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37105112 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35861552 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35656764 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33948272 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33109239 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32729360 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32493806 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32236763 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.31583157 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.31449424 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.31335459 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31236322 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31202872 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30956071 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.29545854 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.28714331 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28427683 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26877059 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.26675767 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26181172 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25736852 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.24115446 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.23769284 |
| 129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23296134 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21919879 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19983182 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.19396359 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19177067 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18684987 |

